{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/veev-stock-analysis/",
 "dataUrl": "https://clearank.com/stock/veev-stock-analysis/data.json",
 "title": "Veeva Systems (VEEV) Stock Forecast & Price Target (2026)",
 "description": "Is Veeva Systems (VEEV) a Buy or Sell today? Get the latest AI trade setup for the life sciences cloud leader, key levels and risk analysis. Updated daily.",
 "headline": "Veeva Systems Inc. (VEEV)",
 "published": "2026-08-29T09:10:56+00:00",
 "modified": "2026-09-11T20:58:19.255+00:00",
 "generated": "2026-09-11T21:01:07.506Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "VEEV",
  "name": "Veeva Systems Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Health Information Services",
  "country": "United States",
  "website": "https://www.veeva.com"
 },
 "quote": {
  "price": 262.25,
  "previousClose": 260.98,
  "change": 1.27,
  "changePercent": 0.49,
  "open": 261.975,
  "high": 263.405,
  "low": 259.54,
  "volume": 63840,
  "averageVolume": 1531484,
  "marketCap": 42460595912,
  "fiftyTwoWeekHigh": 310.5,
  "fiftyTwoWeekLow": 148.050003,
  "marketOpen": false,
  "asOf": "2026-09-11T20:58:18.000Z"
 },
 "statistics": {
  "pe": 43.466663,
  "eps": 6,
  "dividendYield": 0,
  "beta": 0.974,
  "priceToSales": 12.210708,
  "priceToBook": 5.8177924,
  "revenueTtm": 3458097920,
  "grossMargin": 0.7499771003800798,
  "returnOnEquity": 0.14425
 },
 "technicals": {
  "rsi": 57.76,
  "macd": 12.15,
  "sma50": 226.8,
  "sma200": 198.56,
  "rsiSignal": "Neutral",
  "trend": "Bullish",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 73,
  "consensus": "Buy",
  "fairValue": 300,
  "analystTarget": 300,
  "analystCount": 28,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-11T20:58:18.000Z",
  "priceAtAnalysis": 262.25,
  "volatility": {
   "daily": 3.55,
   "risk": "volatile"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 257.01,
  "aggressiveEntry": 262.25,
  "stopLoss": 243.31,
  "stopLossPercent": 5.33,
  "targets": [
   269.86,
   282.71,
   295.56
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 180.43,
    "base": 296.29,
    "upside90th": 486.54
   },
   {
    "year": 2028,
    "downside10th": 166,
    "base": 334.75,
    "upside90th": 675.06
   },
   {
    "year": 2029,
    "downside10th": 160.19,
    "base": 378.2,
    "upside90th": 892.91
   },
   {
    "year": 2030,
    "downside10th": 158.46,
    "base": 427.29,
    "upside90th": 1152.19
   },
   {
    "year": 2031,
    "downside10th": 159.25,
    "base": 482.76,
    "upside90th": 1463.44
   },
   {
    "year": 2032,
    "downside10th": 161.85,
    "base": 545.42,
    "upside90th": 1838.02
   },
   {
    "year": 2033,
    "downside10th": 165.9,
    "base": 616.22,
    "upside90th": 2288.9
   },
   {
    "year": 2034,
    "downside10th": 171.2,
    "base": 696.21,
    "upside90th": 2831.25
   },
   {
    "year": 2035,
    "downside10th": 177.64,
    "base": 786.58,
    "upside90th": 3482.88
   },
   {
    "year": 2036,
    "downside10th": 185.18,
    "base": 888.68,
    "upside90th": 4264.77
   }
  ]
 },
 "faqCount": 8,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "VEEV Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$261.98",
    "Day Range": "$259.54 to $263.41",
    "Prev Close": "$260.98",
    "Volume": "63.8K",
    "52-Week Range": "$148.05 to $310.50",
    "Market Cap": "$42.46B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a significant premium to sector peers (+36%), suggesting market expectations for superior growth or market position."
   ]
  },
  {
   "id": "analysis",
   "title": "VEEV Analysis",
   "text": [
    "Veeva Systems Inc. (VEEV) exhibits neutral momentum with an RSI of 57.76, trading above its 50-day and 200-day moving averages ($226.80 and $198.56). The MACD indicator at 12.15 suggests ongoing positive momentum. Current price action is above the 20-day EMA ($258.84), reinforcing the bullish trend. Volume on the latest trading day was significantly lower than average, which warrants monitoring for sustained conviction behind price movements. Key support is identified around the 50-day SMA, while resistance levels will be tested as the stock approaches its median analyst target price.",
    "Veeva Systems Inc. (VEEV) has a history of exceeding analyst EPS estimates, with the latest quarter showing a 5.86% surprise, indicating strong operational execution and market demand for its services.",
    "The company is projected to achieve 15.00% revenue growth for the current year, significantly outpacing sector averages and demonstrating its ability to capture market share.",
    "A consensus 'Buy' rating from 28 analysts, with a median price target of $300, suggests strong conviction from Wall Street regarding VEEV's future performance.",
    "Officers have sold a total of $23.1 million in VEEV stock, indicating potential concerns or profit-taking among management, which could weigh on sentiment.",
    "VEEV's P/E ratio of 43.47 is above the sector median, making it susceptible to pullbacks if growth falters or market sentiment shifts towards value stocks.",
    "Veeva Systems Inc. (VEEV) is expected to continue its growth trajectory, driven by its strong position in the health information services market and consistent revenue expansion. The current year's revenue is projected to grow by 15.00% to $3.7 billion, with continued growth of 12.00% anticipated for next year. The median analyst price target of $300 suggests that the stock could appreciate by 14.4% from its current trading level of $262.25. Key upside catalysts include continued product innovation and market share gains in cloud-based solutions for the life sciences industry. Potential downside risks involve increased competition and any slowdown in the company's historically strong revenue growth."
   ],
   "lists": {
    "ProTips": [
     "Monitor insider selling activity closely, as $23.1 million in sales have been reported by officers.",
     "Given the stock's premium valuation, consider position sizing carefully and be prepared for potential volatility if growth targets are not met.",
     "Veeva's consistent earnings beats and strong revenue growth provide a solid foundation, but keep an eye on competitive developments in the health tech space."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Consistent Earnings Beats",
     "text": "Veeva Systems Inc. (VEEV) has a history of exceeding analyst EPS estimates, with the latest quarter showing a 5.86% surprise, indicating strong operational execution and market demand for its services.",
     "source": "Earnings Report"
    },
    {
     "type": "Bullish",
     "title": "Strong Revenue Growth",
     "text": "The company is projected to achieve 15.00% revenue growth for the current year, significantly outpacing sector averages and demonstrating its ability to capture market share.",
     "source": "Wall Street Estimates"
    },
    {
     "type": "Bullish",
     "title": "Positive Analyst Sentiment",
     "text": "A consensus 'Buy' rating from 28 analysts, with a median price target of $300, suggests strong conviction from Wall Street regarding VEEV's future performance.",
     "source": "Wall Street Consensus"
    },
    {
     "type": "Bearish",
     "title": "Moderate Insider Selling",
     "text": "Officers have sold a total of $23.1 million in VEEV stock, indicating potential concerns or profit-taking among management, which could weigh on sentiment.",
     "source": "Insider Transactions"
    },
    {
     "type": "Bearish",
     "title": "Premium Valuation",
     "text": "VEEV's P/E ratio of 43.47 is above the sector median, making it susceptible to pullbacks if growth falters or market sentiment shifts towards value stocks.",
     "source": "Fundamental Analysis"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Veeva Systems Inc. (VEEV) trades at a P/E ratio of 43.47, which is above the healthcare sector median of 31.9, indicating a premium valuation. However, its revenue growth of 17.6% significantly exceeds the sector average of 8.1%, justifying some of this premium. The company's earnings per share (EPS) of $6.00 is strong, and recent quarterly earnings have consistently beaten analyst estimates, with the latest quarter showing a 5.86% EPS surprise. The balance sheet appears healthy, with strong revenue growth and consistent earnings beats suggesting efficient operations and a solid market position within health information services.",
    "Veeva Systems Inc. (VEEV) most recently reported Q2 2026 earnings on August 26, 2026, with an EPS of $2.35, beating the estimate of $2.22 by 5.86% and leading to a 15.2% price increase. This follows a pattern of consistent earnings beats, including a 4.67% surprise in Q1 2026 and a significant 16.67% surprise in Q4 2025. The company's revenue growth remains strong, with current year estimates projecting a 15.00% increase year-over-year.",
    "Moderate insider selling, with $23.1 million in sales by officers, presents a near-term risk, although it does not negate the overall positive outlook. The premium valuation, with a P/E ratio above the sector average, could lead to increased volatility if growth expectations are not met. Competition within the health information services sector, while currently managed well by Veeva, remains a persistent factor to monitor."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "42.46B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "43.47"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "6.00"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "310.50"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "148.05"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Neutral SMA Cross Bullish Price vs SMA Bullish MACD Bullish Golden Cross in effect with the 50-day SMA ($226.80) above the 200-day SMA ($198.56), price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "57.76"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "12.15"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "226.80"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "198.56"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.29",
    "Correlation with Nasdaq 100 (QQQ)": "+0.24",
    "Correlation with Bitcoin (BTC)": "+0.28",
    "Correlation with Gold (XAU)": "-0.01"
   }
  },
  {
   "id": "trade-plans",
   "title": "VEEV Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (57.8) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$269.86",
    "TARGET 2": "$282.71",
    "TARGET 3": "$295.56",
    "STOP LOSS": "$243.31"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "3.55%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in VEEV in September 2016 would be worth about $63,966 today, compared with about $35,030 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in VEEV today could grow to about $33,887 by 2036 in the base case, with a bull case near $162,622 and a bear case around $7,061. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "VEEV Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $427 for VEEV by 2030 in the base case, from $262 today (1.6x over 4 years). The downside path ends near $158. These are outcomes of a Monte Carlo simulation run on VEEV's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using VEEV's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "VEEV simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$180",
        "$296",
        "$487"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$166",
        "$335",
        "$675"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$160",
        "$378",
        "$893"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$158",
        "$427",
        "$1,152"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$159",
        "$483",
        "$1,463"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$162",
        "$545",
        "$1,838"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$166",
        "$616",
        "$2,289"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$171",
        "$696",
        "$2,831"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$178",
        "$787",
        "$3,483"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$185",
        "$889",
        "$4,265"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "UNH UnitedHealth Group Inc. NYSE $388.28 -1.22%",
     "url": "https://clearank.com/stock/unitedhealth-group-unh/"
    },
    {
     "text": "ABT Abbott Laboratories NYSE $103.36 -1.78%",
     "url": "https://clearank.com/stock/abbott-laboratories-abt/"
    },
    {
     "text": "OSCR Oscar Health, Inc. NYSE $31.84 +0.2361%",
     "url": "https://clearank.com/stock/oscr-stock-analysis/"
    },
    {
     "text": "MDT Medtronic NYSE $90.78 -0.9223%",
     "url": "https://clearank.com/stock/medtronic-mdt/"
    },
    {
     "text": "MRNA Moderna Inc. NASDAQ $148.15 +8.44%",
     "url": "https://clearank.com/stock/moderna-mrna/"
    },
    {
     "text": "IONS Ionis Pharmaceuticals, Inc. NASDAQ $55.65 -0.6605%",
     "url": "https://clearank.com/stock/ions-stock-analysis/"
    },
    {
     "text": "GILD Gilead Sciences, Inc. NASDAQ $144.81 -0.5767%",
     "url": "https://clearank.com/stock/gilead-sciences-gild/"
    },
    {
     "text": "ZTS Zoetis Inc. NYSE $72.96 +0.1372%",
     "url": "https://clearank.com/stock/zts-stock-analysis/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "Roundhill MAGS vs Invesco QQQ: Magnificent 7 Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/mags-vs-qqq/"
    },
    {
     "text": "VGT vs SMH Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vgt-vs-smh/"
    },
    {
     "text": "VTI vs QQQ Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vti-vs-qqq/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "VEEV Insider Trading Analysis",
   "facts": {
    "Bought": "None",
    "Sold": "$23.1M",
    "Insiders": "16",
    "Avg Transaction": "$1.2M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in VEEV",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Feb 7, 2023",
       "cells": [
        "GASSNER PETER P Chief Executive Officer",
        "Sell",
        "1.4M",
        "$238.8M"
       ]
      },
      {
       "label": "Jan 9, 2023",
       "cells": [
        "GASSNER PETER P Chief Executive Officer",
        "Sell",
        "1.3M",
        "$207.1M"
       ]
      },
      {
       "label": "Dec 9, 2022",
       "cells": [
        "GASSNER PETER P Chief Executive Officer",
        "Sell",
        "132.1K",
        "$22.4M"
       ]
      },
      {
       "label": "Dec 6, 2022",
       "cells": [
        "GASSNER PETER P Chief Executive Officer",
        "Sell",
        "128.3K",
        "$21.4M"
       ]
      },
      {
       "label": "Dec 16, 2022",
       "cells": [
        "GASSNER PETER P Chief Executive Officer",
        "Sell",
        "113.7K",
        "$19.5M"
       ]
      },
      {
       "label": "Dec 13, 2022",
       "cells": [
        "GASSNER PETER P Chief Executive Officer",
        "Sell",
        "89.2K",
        "$15.6M"
       ]
      },
      {
       "label": "Jan 6, 2023",
       "cells": [
        "GASSNER PETER P Chief Executive Officer",
        "Sell",
        "89.2K",
        "$14.5M"
       ]
      },
      {
       "label": "Aug 13, 2026",
       "cells": [
        "SCHWENGER THOMAS D President",
        "Sell",
        "36.0K",
        "$9.0M"
       ]
      },
      {
       "label": "Sep 13, 2021",
       "cells": [
        "CODD RONALD EDGAR FORBES Director",
        "Sell",
        "23.1K",
        "$6.9M"
       ]
      },
      {
       "label": "Dec 23, 2020",
       "cells": [
        "CODD RONALD EDGAR FORBES Director",
        "Sell",
        "20.0K",
        "$5.8M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Veeva+Systems+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is Veeva Systems Inc. (VEEV) stock a buy right now?",
   "answer": "Veeva Systems Inc. (VEEV) is currently rated a Buy by Wall Street analysts, with a consensus score of 73 out of 100. The median analyst price target of $300 suggests a potential upside of 14.4% from the current price of $262.25."
  },
  {
   "question": "What is Veeva Systems Inc.'s (VEEV) outlook for the next 12 months?",
   "answer": "The outlook for Veeva Systems Inc. (VEEV) is positive, supported by strong revenue growth projections of 15.00% for the current year and 12.00% for the next year. Analysts anticipate continued performance, with a median price target of $300."
  },
  {
   "question": "What are the main risks facing Veeva Systems Inc. (VEEV)?",
   "answer": "Key risks for Veeva Systems Inc. (VEEV) include moderate insider selling totaling $23.1 million and a P/E ratio that trades at a premium to the sector average. Competitive pressures within the health information services industry also warrant attention."
  },
  {
   "question": "How has Veeva Systems Inc. (VEEV) performed in recent earnings reports?",
   "answer": "Veeva Systems Inc. (VEEV) has a strong track record of beating earnings estimates, with its most recent Q2 2026 report showing a 5.86% EPS surprise. This consistent performance has generally been met with positive stock price reactions."
  },
  {
   "question": "What is Veeva Systems Inc.'s (VEEV) P/E ratio compared to its sector?",
   "answer": "Veeva Systems Inc. (VEEV) has a P/E ratio of 43.47, which is higher than the healthcare sector median of 31.9. This suggests the stock is trading at a premium, likely reflecting its superior revenue growth and market position."
  },
  {
   "question": "What are the technical indicators for Veeva Systems Inc. (VEEV)?",
   "answer": "Technical indicators for Veeva Systems Inc. (VEEV) are largely positive, with the stock trading above its 50-day and 200-day moving averages ($226.80 and $198.56) and showing neutral RSI momentum (57.76). The MACD also indicates positive momentum."
  },
  {
   "question": "What is Veeva Systems Inc.'s (VEEV) projected revenue growth?",
   "answer": "Veeva Systems Inc. (VEEV) is projected to achieve revenue growth of 15.00% for the current year and 12.00% for the next year, significantly outpacing the healthcare sector average of 8.1%."
  },
  {
   "question": "What is Veeva Systems Inc.'s (VEEV) stock price prediction for 2030?",
   "answer": "Based on Monte Carlo simulations, Veeva Systems Inc.'s (VEEV) stock price is projected to be $427.29 in 2030 under a base case scenario, with a downside projection of $158.46 and an upside projection of $1152.19. These are statistical outcomes, not guarantees."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "UNH",
    "name": "UnitedHealth Group Inc. NYSE",
    "price": "$388.28",
    "change": "-1.22%",
    "url": "https://clearank.com/stock/unitedhealth-group-unh/"
   },
   {
    "ticker": "ABT",
    "name": "Abbott Laboratories NYSE",
    "price": "$103.36",
    "change": "-1.78%",
    "url": "https://clearank.com/stock/abbott-laboratories-abt/"
   },
   {
    "ticker": "OSCR",
    "name": "Oscar Health, Inc. NYSE",
    "price": "$31.84",
    "change": "+0.2361%",
    "url": "https://clearank.com/stock/oscr-stock-analysis/"
   },
   {
    "ticker": "MDT",
    "name": "Medtronic NYSE",
    "price": "$90.78",
    "change": "-0.9223%",
    "url": "https://clearank.com/stock/medtronic-mdt/"
   },
   {
    "ticker": "MRNA",
    "name": "Moderna Inc. NASDAQ",
    "price": "$148.15",
    "change": "+8.44%",
    "url": "https://clearank.com/stock/moderna-mrna/"
   },
   {
    "ticker": "IONS",
    "name": "Ionis Pharmaceuticals, Inc. NASDAQ",
    "price": "$55.65",
    "change": "-0.6605%",
    "url": "https://clearank.com/stock/ions-stock-analysis/"
   },
   {
    "ticker": "GILD",
    "name": "Gilead Sciences, Inc. NASDAQ",
    "price": "$144.81",
    "change": "-0.5767%",
    "url": "https://clearank.com/stock/gilead-sciences-gild/"
   },
   {
    "ticker": "ZTS",
    "name": "Zoetis Inc. NYSE",
    "price": "$72.96",
    "change": "+0.1372%",
    "url": "https://clearank.com/stock/zts-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "Roundhill MAGS vs Invesco QQQ: Magnificent 7 Comparison",
    "name": "",
    "url": "https://clearank.com/compare/mags-vs-qqq/"
   },
   {
    "ticker": "VGT vs SMH Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vgt-vs-smh/"
   },
   {
    "ticker": "VTI vs QQQ Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vti-vs-qqq/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "NTES",
    "text": "NetEase, Inc.",
    "url": "https://clearank.com/stock/ntes-stock-analysis/"
   },
   {
    "ticker": "PCAR",
    "text": "PACCAR Inc.",
    "url": "https://clearank.com/stock/pcar-stock-analysis/"
   },
   {
    "ticker": "O",
    "text": "Realty Income Corp.",
    "url": "https://clearank.com/stock/o-stock-analysis/"
   },
   {
    "ticker": "SPG",
    "text": "Simon Property Group Inc.",
    "url": "https://clearank.com/stock/spg-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "NEAR/USD",
    "text": "↑ 18.46%",
    "url": "https://clearank.com/crypto/near-protocol-near-usd/"
   },
   {
    "ticker": "THETA/USD",
    "text": "↑ 15.25%",
    "url": "https://clearank.com/crypto/theta-network-theta-usd/"
   },
   {
    "ticker": "HPE",
    "text": "↑ 10.41%",
    "url": "https://clearank.com/stock/hewlett-packard-enterprise-hpe/"
   },
   {
    "ticker": "DELL",
    "text": "↑ 10.23%",
    "url": "https://clearank.com/stock/dell-technologies-dell/"
   },
   {
    "ticker": "IMSR",
    "text": "↓ 9.79%",
    "url": "https://clearank.com/stock/terrestrial-energy-imsr/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "TEM",
    "text": "Tempus AI Inc",
    "url": "https://clearank.com/stock/tempus-ai-tem/"
   },
   {
    "ticker": "TMO",
    "text": "Thermo Fisher",
    "url": "https://clearank.com/stock/tmo-stock-analysis/"
   },
   {
    "ticker": "UNH",
    "text": "UnitedHealth Group",
    "url": "https://clearank.com/stock/unitedhealth-group-unh/"
   },
   {
    "ticker": "VKTX",
    "text": "Viking Therapeutics Inc",
    "url": "https://clearank.com/stock/viking-therapeutics-vktx/"
   },
   {
    "ticker": "VRTX",
    "text": "Vertex Pharmaceuticals",
    "url": "https://clearank.com/stock/vertex-vrtx/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/08/veev-veeva-systems-analysis-2026-08.png",
     "url": "https://clearank.com/wp-content/uploads/2026/08/veev-veeva-systems-analysis-2026-08.png",
     "width": "1280",
     "height": "720",
     "caption": "Veeva Systems (VEEV) stock price analysis chart for August 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/veev-stock-analysis/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/veev-stock-analysis/",
        "name": "Veeva Systems Inc. (VEEV) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/veev-stock-analysis/#webpage",
     "url": "https://clearank.com/stock/veev-stock-analysis/",
     "name": "Veeva Systems (VEEV) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-08-29T09:10:56+00:00",
     "dateModified": "2026-09-11T20:58:19+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/08/veev-veeva-systems-analysis-2026-08.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/veev-stock-analysis/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Veeva Systems (VEEV) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-08-29T09:10:56+00:00",
     "dateModified": "2026-09-11T20:58:19+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Is Veeva Systems (VEEV) a Buy or Sell today? Get the latest AI trade setup for the life sciences cloud leader, key levels and risk analysis. Updated daily.",
     "name": "Veeva Systems (VEEV) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/veev-stock-analysis/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/veev-stock-analysis/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/08/veev-veeva-systems-analysis-2026-08.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/veev-stock-analysis/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Veeva Systems Inc. (VEEV)",
   "tickerSymbol": "VEEV",
   "url": "https://clearank.com/stock/veev-stock-analysis/",
   "description": "AI-powered financial analysis for Veeva Systems Inc. (VEEV) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NYSE",
   "offers": {
    "@type": "Offer",
    "price": 262.25,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/veev-stock-analysis/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is Veeva Systems Inc. (VEEV) stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Veeva Systems Inc. (VEEV) is currently rated a Buy by Wall Street analysts, with a consensus score of 73 out of 100. The median analyst price target of $300 suggests a potential upside of 14.4% from the current price of $262.25."
     }
    },
    {
     "@type": "Question",
     "name": "What is Veeva Systems Inc.'s (VEEV) outlook for the next 12 months?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The outlook for Veeva Systems Inc. (VEEV) is positive, supported by strong revenue growth projections of 15.00% for the current year and 12.00% for the next year. Analysts anticipate continued performance, with a median price target of $300."
     }
    },
    {
     "@type": "Question",
     "name": "What are the main risks facing Veeva Systems Inc. (VEEV)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks for Veeva Systems Inc. (VEEV) include moderate insider selling totaling $23.1 million and a P/E ratio that trades at a premium to the sector average. Competitive pressures within the health information services industry also warrant attention."
     }
    },
    {
     "@type": "Question",
     "name": "How has Veeva Systems Inc. (VEEV) performed in recent earnings reports?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Veeva Systems Inc. (VEEV) has a strong track record of beating earnings estimates, with its most recent Q2 2026 report showing a 5.86% EPS surprise. This consistent performance has generally been met with positive stock price reactions."
     }
    },
    {
     "@type": "Question",
     "name": "What is Veeva Systems Inc.'s (VEEV) P/E ratio compared to its sector?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Veeva Systems Inc. (VEEV) has a P/E ratio of 43.47, which is higher than the healthcare sector median of 31.9. This suggests the stock is trading at a premium, likely reflecting its superior revenue growth and market position."
     }
    },
    {
     "@type": "Question",
     "name": "What are the technical indicators for Veeva Systems Inc. (VEEV)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Technical indicators for Veeva Systems Inc. (VEEV) are largely positive, with the stock trading above its 50-day and 200-day moving averages and showing neutral RSI momentum (57.76). The MACD also indicates positive momentum."
     }
    },
    {
     "@type": "Question",
     "name": "What is Veeva Systems Inc.'s (VEEV) projected revenue growth?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Veeva Systems Inc. (VEEV) is projected to achieve revenue growth of 15.00% for the current year and 12.00% for the next year, significantly outpacing the healthcare sector average of 8.1%."
     }
    },
    {
     "@type": "Question",
     "name": "What is Veeva Systems Inc.'s (VEEV) stock price prediction for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, Veeva Systems Inc.'s (VEEV) stock price is projected to be $427.29 in 2030 under a base case scenario, with a downside projection of $158.46 and an upside projection of $1152.19. These are statistical outcomes, not guarantees."
     }
    }
   ]
  }
 ]
}